Acelyrin Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2005
Period Ending	Dec '05 Dec 31, 2005
Revenue	250
Gross Profit	250
Selling, General & Admin	240
Operating Expenses	240
Operating Income	10
Other Non Operating Income (Expenses)	-10
Shares Outstanding (Basic)	4
Shares Outstanding (Diluted)	4
Gross Margin	100.00%
Operating Margin	4.00%
EBIT	10
EBIT Margin	4.00%

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q